MML Investors Services’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,829
| Closed | -$222K | – | 2798 |
|
2024
Q4 | $222K | Buy |
+1,829
| New | +$222K | ﹤0.01% | 2452 |
|
2024
Q3 | – | Sell |
-8,574
| Closed | -$1.36M | – | 2629 |
|
2024
Q2 | $1.36M | Buy |
+8,574
| New | +$1.36M | 0.01% | 1239 |
|
2021
Q1 | – | Sell |
-3,268
| Closed | -$557K | – | 1838 |
|
2020
Q4 | $557K | Sell |
3,268
-65
| -2% | -$11.1K | 0.01% | 1104 |
|
2020
Q3 | $468K | Sell |
3,333
-107
| -3% | -$15K | 0.01% | 1074 |
|
2020
Q2 | $552K | Sell |
3,440
-1,871
| -35% | -$300K | 0.01% | 949 |
|
2020
Q1 | $520K | Buy |
+5,311
| New | +$520K | 0.01% | 846 |
|
2019
Q3 | – | Sell |
-2,230
| Closed | -$339K | – | 1594 |
|
2019
Q2 | $339K | Buy |
2,230
+167
| +8% | +$25.4K | ﹤0.01% | 1216 |
|
2019
Q1 | $246K | Buy |
2,063
+223
| +12% | +$26.6K | ﹤0.01% | 1369 |
|
2018
Q4 | $201K | Sell |
1,840
-339
| -16% | -$37K | ﹤0.01% | 1382 |
|
2018
Q3 | $352K | Buy |
2,179
+299
| +16% | +$48.3K | 0.01% | 1195 |
|
2018
Q2 | $248K | Sell |
1,880
-864
| -31% | -$114K | 0.01% | 1170 |
|
2018
Q1 | $203K | Sell |
2,744
-6,282
| -70% | -$465K | ﹤0.01% | 1276 |
|
2017
Q4 | $502K | Sell |
9,026
-1,383
| -13% | -$76.9K | 0.01% | 838 |
|
2017
Q3 | $472K | Buy |
10,409
+2,297
| +28% | +$104K | 0.01% | 809 |
|
2017
Q2 | $273K | Buy |
+8,112
| New | +$273K | 0.01% | 1021 |
|